Fluzone High-dose Quadrivalent Northern Hemisphere
Product Images NDC 49281-226

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fluzone High-dose Quadrivalent Northern Hemisphere (NDC 49281-226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Pasteur Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.7 mL Syringe Label)

Principal Display Panel (0.7 mL Syringe Label)
Label for Fluzone High-Dose Quadrivalent Northern Hemisphere influenza vaccine, 0.7 mL single-dose vial for intramuscular use. The label includes the NDC 49281-122-88, indicates it is for adults 65 years and older, and is manufactured by Sanofi Pasteur Inc. Spaces are reserved on the label for lot number and expiration date.*
FDA Label Image

Principal Display Panel (0.7 mL Syringe Package)

Principal Display Panel (0.7 mL Syringe Package)
Label for Fluzone High-Dose Quadrivalent influenza vaccine, 0.7 mL single-dose vial, 2022-2023 formula for ages 65 and older. Manufactured by Sanofi Pasteur Inc. Label includes the NDC 49281-122-88, barcode, and designated areas reserved for lot and expiry information.*
FDA Label Image

Fluzone 03

Fluzone 03
Packaging label for Fluzone High-Dose Quadrivalent Influenza Vaccine 2022–2023 Formula by Sanofi Pasteur Inc. The label specifies it is for adults 65 and older, for intramuscular injection only. The package contains 10 single-dose prefilled syringes, each with 0.7 mL. The label features dosing and storage information and includes the product NDC 49281-122-65 along with Sanofi Pasteur branding and manufacturing details.*
FDA Label Image

Fluzone 04

Fluzone 04
Fluzone High-Dose Quadrivalent Influenza Vaccine carton for adults 65+, manufactured by Sanofi Pasteur Inc. It is a 2022-2023 formula containing 10 single-dose prefilled syringes of 0.7 mL each for intramuscular injection. The packaging includes storage instructions and vaccine strain information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.